Proventil (albuterol)
/ Merck (MSD)
- LARVOL DELTA
Home
Next
Prev
1 to 18
Of
18
Go to page
1
November 19, 2024
Correct use of inhalers for asthma.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
November 19, 2024
Drugs for asthma.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
February 20, 2024
Projected Savings on Inhalers Purchased Via Mark Cuban Cost Plus Drug Company (MCCPDC) Versus Medicare Part-D
(ATS 2024)
- "Top Pulmonology inhalers studied were Albuterol Sulfate (Ventolin), Albuterol Sulfate (Proair), Albuterol sulfate (Proventil), Albuterol Sulfate HFA, Fluticasone Salmeterol (Advair Diskus) and Fluticasone Salmeterol (Advair HFA). Purchasing prescription drugs through MCCPDC showed substantial potential cost-savings for pulmonology directed rugs. MCCPDC could be a reasonable financial alternative for Medicare Part D spending on pulmonology drugs to reduce the financial burden of healthcare related costs."
Medicare • Reimbursement • US reimbursement • Alpha-1 Antitrypsin Deficiency • Chronic Obstructive Pulmonary Disease • Critical care • Genetic Disorders • Immunology • Pulmonary Disease • Respiratory Diseases
March 11, 2024
Airsupra: An inhaled albuterol/budesonide combination for asthma.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
December 01, 2021
"@Walgreens @WAGSocialCare @Healthcare_ABC @Advoccy_ABC @AmerisourceBer1 @Merck @USMerckProducts @POTUS @SpeakerPelosi @RepAdamSchiff: I am an asthmatic for 50 years and I use a live saving inhaler - #Proventil. I was told by Walgreens that AmerisourceBergen will not supply /1"
(@ursusduras)
Asthma • Immunology • Respiratory Diseases
September 11, 2021
AstraZeneca’s MANDALA & DENALI phase III trials of FDC albuterol and budesonide to treat asthma meets primary endpoints
(Pharmabiz)
- "Bradley E. Chipps...said: 'Severe asthma exacerbations are a significant burden for many asthma patients of all ages resulting in impaired quality of life, hospitalisation, treatment with systemic corticosteroids which can lead to serious side effects, and the possibility of premature death....The MANDALA and DENALI trials demonstrate an albuterol/budesonide rescue inhaler can address inflammation and prevent exacerbations, making PT027 an important potential new treatment option for patients.'"
Media quote • Asthma
June 06, 2021
Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials.
(PubMed, Clin Drug Investig)
- P2 | "The effects of albuterol delivered via AS MDI and Proventil on bronchodilation were equivalent, supporting the selection of AS MDI 180 µg to be taken into Phase III clinical trials, either alone or in combination with an inhaled corticosteroid."
Clinical • Journal • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
January 16, 2021
Drugs for asthma.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Asthma • Immunology • Respiratory Diseases
January 16, 2021
Expanded table: Correct use of inhalers for asthma.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Asthma • Immunology • Respiratory Diseases
January 16, 2021
Expanded table: Some inhaled drugs for treatment of asthma.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Asthma • Immunology • Respiratory Diseases
October 23, 2020
Zydus Cadila gets USFDA nod for generic drug
(Yahoo Finance)
- "The company has received final approval from the US Food and Drug Administration (USFDA) to market its product, which is a generic version of Proventil tablets, Zydus Cadila said in a statement."
Generic launch • Asthma • Respiratory Diseases
September 23, 2020
Drugs for COPD.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Chronic Obstructive Pulmonary Disease • Infectious Disease • Tobacco Cessation
September 23, 2020
Comparison table: Inhaled short-acting bronchodilators for treatment of COPD.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Chronic Obstructive Pulmonary Disease
September 23, 2020
Table: Correct Use of inhalers for COPD.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Asthma • Chronic Obstructive Pulmonary Disease • Respiratory Diseases
July 15, 2020
[VIRTUAL] In vitro fine particle dose of drug formulation used in asthma & COPD
(ERS 2020)
- "The 7 pMDI drugs (Table 1) included 2 inhaled corticosteroids (Flovent and QVAR), 1 anticholinergic (Atrovent) and 4 bronchodilator formulations of salbutamol sulphate (SALB; Ventolin Evohaler sold in the UK, Ventolin HFA, Proventil and ProAir HFA sold in the USA). Mean FPD (μg ± standard deviation) FPD from the pMDI with VHC was equivalent or greater than pMDI alone. Although the 4 bronchodilator drug formulations delivered the same drug (SALB) the FPD differed by up to a factor of 2."
Preclinical • Asthma • Chronic Obstructive Pulmonary Disease • Respiratory Diseases
September 02, 2020
Comparison of Nebulizers in ED in Pediatric Asthma Patients
(clinicaltrials.gov)
- P4; N=40; Terminated; Sponsor: Seton Healthcare Family; N=242 ➔ 40; Completed ➔ Terminated; No data are available for this study as the PI has left the institution.
Clinical • Enrollment change • Trial termination • Asthma • Pediatrics • Respiratory Diseases
April 16, 2020
"Is there a Proventil inhaler shortage?"
(@crtsgt)
April 09, 2020
Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)
(clinicaltrials.gov)
- P3; N=402; Completed; Sponsor: University of Illinois at Chicago; Active, not recruiting ➔ Completed; Trial completion date: Jul 2020 ➔ Sep 2019
Clinical • Trial completion • Trial completion date
1 to 18
Of
18
Go to page
1